This art icle was downloaded by: [ 191.191.99.62]On: 04 March 2015, At : 05: 02Publisher: Rout ledgeI nform a Ltd Registered in England and Wales Registered Num ber: 1072954 Registered office: Mort im er House,37-41 Mort im er St reet , London W1T 3JH, UK
Click for updates
Nutrition and CancerPublicat ion det ails, including inst ruct ions for aut hors and subscript ion informat ion:ht t p: / / www. t andfonl ine.com/ loi/ hnuc20
Individuals with Hematological Malignancies BeforeUndergoing Chemotherapy Present Oxidative StressParameters and Acute Phase Proteins Correlated withNutritional StatusCarol ina de Quadros Camargoa, Dayanne da Silva Borgesa, Paula Fernanda de Oliveiraa,
Thayz Rodrigues Chagasa, Joanit a Angela Gonzaga Del Moralb, Giovanna St ef fanel lo Durigonb,
Bruno Vieira Diasb, André Guedes Vieirab, Pat rick Gasparet oc, Erasmo Benício Sant os de
Moraes Trindadea & Everson Araúj o Nunesa
a Post graduat e Program in Nut rit ion, Federal Universit y of Sant a Cat arina, Florianópol is,Brazilb Hemat ology Depart ment , Universit y Hospit al of Federal Universit y of Sant a Cat arina,Florianópol is, Brazilc Pharmacy, Universit y Hospit al of Federal Universit y of Sant a Cat arina, Florianópol is, BrazilPubl ished onl ine: 24 Feb 2015.
To cite this article: Carol ina de Quadros Camargo, Dayanne da Silva Borges, Paula Fernanda de Oliveira, Thayz RodriguesChagas, Joanit a Angela Gonzaga Del Moral, Giovanna St ef fanel lo Durigon, Bruno Vieira Dias, André Guedes Vieira, Pat rickGasparet o, Erasmo Benício Sant os de Moraes Trindade & Everson Araúj o Nunes (2015): Individuals wit h Hemat ologicalMal ignancies Before Undergoing Chemot herapy Present Oxidat ive St ress Paramet ers and Acut e Phase Prot eins Correlat ed wit hNut rit ional St at us, Nut rit ion and Cancer, DOI: 10.1080/ 01635581.2015.1004732
To link to this article: ht t p: / / dx.doi.org/ 10.1080/ 01635581.2015.1004732
PLEASE SCROLL DOWN FOR ARTI CLE
Taylor & Francis m akes every effort to ensure the accuracy of all the inform at ion ( the “Content ” ) containedin the publicat ions on our plat form . However, Taylor & Francis, our agents, and our licensors m ake norepresentat ions or warrant ies whatsoever as to the accuracy, com pleteness, or suitability for any purpose of theContent . Any opinions and views expressed in this publicat ion are the opinions and views of the authors, andare not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon andshould be independent ly verified with pr im ary sources of inform at ion. Taylor and Francis shall not be liable forany losses, act ions, claim s, proceedings, dem ands, costs, expenses, dam ages, and other liabilit ies whatsoeveror howsoever caused arising direct ly or indirect ly in connect ion with, in relat ion to or ar ising out of the use ofthe Content .
This art icle m ay be used for research, teaching, and private study purposes. Any substant ial or systemat icreproduct ion, redist r ibut ion, reselling, loan, sub- licensing, system at ic supply, or dist r ibut ion in anyform to anyone is expressly forbidden. Term s & Condit ions of access and use can be found at ht tp: / /www.tandfonline.com / page/ term s-and-condit ions
Individuals with Hematological Malignancies BeforeUndergoing Chemotherapy Present Oxidative StressParameters and Acute Phase Proteins Correlatedwith Nutritional Status
Carolina de Quadros Camargo, Dayanne da Silva Borges, Paula Fernanda de Oliveira,
and Thayz Rodrigues ChagasPostgraduate Program in Nutrition, Federal University of Santa Catarina, Florian�opolis, Brazil
Joanita Angela Gonzaga Del Moral, Giovanna Steffanello Durigon, Bruno Vieira Dias,
and Andr�e Guedes VieiraHematology Department, University Hospital of Federal University of Santa Catarina, Florian�opolis,
Brazil
Patrick GasparetoPharmacy, University Hospital of Federal University of Santa Catarina, Florian�opolis, Brazil
Erasmo Ben�ıcio Santos de Moraes Trindade and Everson Ara�ujo NunesPostgraduate Program in Nutrition, Federal University of Santa Catarina, Florian�opolis, Brazil
Hematological malignancies present abnormal blood cells thatmay have altered functions. This study aimed to evaluatenutritional status, acute phase proteins, parameters of cell’sfunctionality, and oxidative stress of patients with hematologicalmalignancies, providing a representation of these variables atdiagnosis, comparisons between leukemias and lymphomas andestablishing correlations. Nutritional status, C-reactive protein(CRP), albumin, phagocytic capacity and superoxide anionproduction of mononuclear cells, lipid peroxidation and catalaseactivity in plasma were evaluated in 16 untreated subjects. Maindiagnosis was acute leukemia (n D 9) and median body massindex (BMI) indicated overweight (25.6 kg/m2). Median albuminwas below (3.2 g/dL) and CRP above (37.45 mg/L) the referencevalues. Albumin was inversely correlated with BMI (r D ¡0.53).Most patients were overweight before the beginning of treatmentand had a high CRP/albumin ratio, which may indicate anutrition inflammatory risk. BMI values correlated positivelywith lipid peroxidation and catalase activity. A strong correlationbetween catalase activity and lipid peroxidation was found (r D0.75). Besides the elevated BMI, these patients also have elevatedCRP values and unexpected relations between nutritional statusand albumin, reinforcing the need for nutritional counselingduring the course of chemotherapy, especially considering the
correlations between oxidative stress parameters and nutritionalstatus evidenced here.
INTRODUCTION
Cancer is characterized by uncontrolled growth of cells
which might invade tissues and metastasize to distant sites,
causing the host morbidity and, in some cases, death (1).
Hematological malignancies are usually initiated in blood-
forming or immune-related tissues, which start to produce
abnormal cells. The most prevalent diseases in such group are
leukemias and lymphomas. In individuals with leukemia, leu-
kocytes do not perform adequately normal functions and cells
remain for a longer time in the bloodstream. Leukemias can be
divided into chronic and acute forms. The former is character-
ized by slower development and gradual worsening of cell
functions, whereas acute leukemia is characterized by a rapid
increase of abnormal cells in the bloodstream. Lymphomas
can be divided into Hodgkin lymphoma and non-Hodgkin’s,
malignant diseases of the lymphatic system, also considered
hematological malignancies (2).
Mononuclear cells are a heterogeneous group of leukocytes
with several distinct functions. The interaction among them is
responsible for many attributes of the immune system. As an
example, monocytes are recruited to tissues to promote death
of pathogens through the release of reactive oxygen (ROS)
Submitted 17 September 2013; accepted in final form18 November 2014
Address correspondence to Carolina de Quadros Camargo, Post-graduate Program in Nutrition, Federal University of Santa Catarina,Florian�opolis, Brazil. E-mail: [email protected]
1
Nutrition and Cancer, 0(0), 1–9
Copyright � 2015, Taylor & Francis Group, LLC
ISSN: 0163-5581 print / 1532-7914 online
DOI: 10.1080/01635581.2015.1004732
Dow
nloa
ded
by [
191.
191.
99.6
2] a
t 05:
02 0
4 M
arch
201
5
and nitrogen species, phagocytosis of microorganisms and cell
debris, and also to perform antigen presentation to T cells, trig-
gering a specific defense both against microorganisms and, in
some cases, neoplastic cells. As the functionality of one or sev-
eral immune cells can be altered in hematological malignan-
cies, it is difficult to foresee how such cells are operating in
these diseases (3,4).
Production of ROS and antioxidant enzymes activity are
also altered in patients with hematological malignancies (5).
When not properly neutralized by antioxidant enzymes, reac-
tive species can trigger the formation of chain reactions with
polyunsaturated fatty acids present in the cells’ membrane
lipid bilayer, a process called lipid peroxidation (6). However,
the production of ROS may exert different actions on prolifer-
ation or survival of cells. Although oxidative stress is com-
monly discussed as an important character in carcinogenesis,
malignant cells are also usually sensitive to lipid peroxidation
products (7). Therefore, it is important to know how some of
these parameters are established in these diseases.
Besides the issues regarding cells functionality and the bal-
ance between oxidative stress and antioxidant systems, the
nutritional state is an additional relevant clinical aspect in can-
cer patients. Especially during the course of treatment, acute
phase proteins can be altered as well as the nutritional state
which can be negatively affected, compromising the prognosis
and survival of these patients (8,9). Therefore, to know the
pretreatment nutritional state in such diseases might be an
effective strategy to foreseen, at least in part, the capacity of
the subject in resisting the aggressiveness of the therapeutic
process. Furthermore, the relation between the pretreatment
nutritional state and mononuclear cells functionality is not
completely known in hematological malignancies.
Considering the functionality of mononuclear cells and oxi-
dative stress in hematological malignancies, the relevance of
these parameters and the unknown relations of them with the
pre-treatment nutritional state in these diseases, this study
aimed these parameters in leukemia and lymphoma patients.
In addition, differences among these variables between both
diagnosis and correlations were assayed.
METHODS
This is a descriptive study of the patients diagnosed with
hematological malignancies at the University Hospital of the
Federal University of Santa Catarina, before initiating chemo-
therapy treatment, recruited between November 2012 and
April 2013. All procedures involving human subjects were
approved by the Human Research Ethics Committee of the
Federal University of Santa Catarina. Inclusion criteria were
16 yr or more, hematological malignancy diagnosis, and indi-
cation of chemotherapy treatment. Exclusion criteria included
palliative care, radiotherapy, impossibility of oral ingestion, a
diagnosis of infectious disease, and treatment that included
statins and/or antiinflammatory medicines. All recruited
patients, who accepted to participate, gave written informed
consent. Data collection was performed at the University Hos-
pital of the Federal University of Santa Catarina. At study
entry, anthropometric data were collected and a blood sample
taken, immediately prior to initiating chemotherapy. Nutri-
tional status, C-reactive protein (CRP), and albumin were
assessed. Mononuclear cells’ functions were assessed by
phagocytosis of zymosan and superoxide anion production. To
assess oxidative stress parameters, plasma catalase activity
and plasma lipid hydroperoxides were evaluated.
Nutritional Status and Characterization Data
Anthropometric data were measured by a nutritionist, using
a platform digital scale, Tanita�, model A 061 (Company
Tanita Corporation, Tokyo, Japan), and an inelastic tape to
measure weight and height, respectively. The usual weight
(last 6 mo) was self-reported by the participant. Triceps skin-
folds were measured with Lange Skinfold Caliper California�
anthropometer (Beta Technology Incorporated, Santa Cruz,
CA) and arm circumference [used to calculate mid-upper arm
muscle circumference (MUAMC)] with an inelastic tape. The
adequacy of the MUAMC was calculated dividing mid-upper
arm muscle circumference obtained by mid-upper arm muscle
circumference of the 50th percentile considering sex and age
of the individual, according to Frisancho (10). All anthropo-
metric measurements followed standard techniques (11). Body
mass index (BMI) was calculated dividing weight by the
square of the height (11) and percentage of weight loss (in the
last 6 mo) was the ratio between the difference of the current
and usual weight and current weight of the individual, multi-
plied by 100. Date of birth, diagnosis and comorbidities were
obtained from the patient’s chart.
Isolation of Plasma and Mononuclear Cells
Venous blood samples were collected into tubes containing
lithium-heparin as anticoagulant. Blood was centrifuged
(400 g) and the plasma was collected after centrifugation and
frozen immediately at ¡80�C for posterior catalase and lipid
peroxidation assays. Mononuclear cells were isolated by cen-
trifugation on a Ficoll-PaqueTM PLUS gradient. Cells were
collected and washed twice with saline. Afterwards, cells were
resuspended in RPMI 1640 culture medium (Sigma-Aldrich
Co., St. Louis, MO, USA) and the number of cells was deter-
mined using an automated cell counter (Advia� 60 Hematol-
ogy System, Bayer, Leverkusen, Germany). Cells were used
for functional assays immediately after cell isolation.
Cell Adhesion
An aliquot of a suspension containing 106 mononuclear
cells/ml was placed in each assay well of a 96-well cell culture
plate and incubated at 37�C for 1 h. The culture medium was
2 C. DE QUADROS CAMARGO ET AL.
Dow
nloa
ded
by [
191.
191.
99.6
2] a
t 05:
02 0
4 M
arch
201
5
discarded and 50% methanol was added for fixation. After
10 min, a Giemsa solution was added and incubated for addi-
tional 40 min at room temperature. The supernatant was dis-
carded and the wells were washed. Finally, 50% methanol was
added and, after 30 min at room temperature, the plates were
read at 550 nm using a microplate reader (12) (Apollo-8
Absorbance Microplate Reader LB 912, Berthold Technolo-
gies GmbH & Co. KG, Bad Wildbad, Germany).
Phagocytosis of Zymosan by Mononuclear Cells
The method described by Pipe et al. (13) was adapted.
Mononuclear cells were seeded in 96-well flat-bottomed tissue
culture plates (105 cells in 100 mL). Neutral red-stained zymo-
san was added and the plates were incubated for 30 min.
Then, cells were fixed with Baker’s formol-calcium solution
(4% formaldehyde, 2% sodium chloride, 1% calcium acetate)
for 30 min. The neutral red stain was extracted with 0.1 mL of
acidified alcohol (10% acetic acid, 40% ethanol in distilled
water) for 30 min. The absorbance was read on a microplate
reader at 550 nm and the results normalized by cell adhesion.
Superoxide Anion Production by Mononuclear Cells
Superoxide anion production by mononuclear cells was
measured by the reduction of nitroblue tetrazolium, using the
method described by Choi et al. (14). Suspensions containing
105 mononuclear cells were incubated at 37�C in the presence
of phorbol 12-myristate 13-acetate and nitroblue tetrazolium.
Then, cells were fixed with 50% methanol for 10 min and air-
dried. Reduction of nitroblue tetrazolium results in the forma-
tion of blue formazan, which was solubilized by 30 min incu-
bation with potassium hydroxide and dimethyl sulfoxide per
well. The absorbance was read at 550 nm and the results were
normalized by cell adhesion.
Plasma Catalase Activity
This assay was adapted from the procedures described by
Aebi (15). Data were expressed as mmol of consumption of
H2O2 per minute and normalized by plasma protein concentra-
tion (protein concentration was measured using the method of
Bradford) (16).
Plasma Lipid Hydroperoxides
The method described by Nourooz-Zadeh et al. (17) was
used. The plasma was homogenized with methanol and then
centrifuged. The supernatant was transferred to 6 wells of a
96-well plate; 3 of these wells triphenyl phosphate (TPP) was
added and only methanol was added in the remaining three.
The samples were incubated for 30 min and then added a
FOX-2 solution and incubated again. The absorbance was read
at 550 nm. The value of absorbance of the samples treated
with TPP was subtracted from the absorbance value of the
samples without TPP, a standard curve is made with known
concentrations of hydrogen peroxide. The results were
expressed in mmol /mg of protein.
Quantification of CRP, Albumin, and Hemogram
CRP was determined by immunonephelometry (Siemens
Dade Behring Inc., Newark, DE) (18) and albumin was deter-
mined by an automated colorimetric method (Siemens Health-
care Diagnostics Inc., Newark, DE) using bromocresol purple
as a color reagent (19). To obtain a complete blood count an
automated hematology analyzer Sysmex XE-2100D (Sysmex
Corporation, Kobe, Hyogo, Japan) was used.
Statistical Analyses
Quantitative variables are presented as median and inter-
quartile range considering all were asymmetric. Categorical
variables are presented in categories and frequencies. To cor-
relate variables, Pearson or Spearman tests were used accord-
ing to data distribution, after logarithmic transformation. To
compare results of leukemias and lymphomas diagnosis,
Mann-Whitney test was used, differences were considered sta-
tistically significant at P < 0.05. Statistical analyses were per-
formed using STATA� statistical software version 11.0 for
Windows (StataCorp, TX).
RESULTS
Characteristics of the Study Subjects
Thirty-seven new patients diagnosed with hematological
malignancies were treated by the medical staff at the Univer-
sity Hospital of the Federal University of Santa Catarina in the
period of November 2012 to April 2013. Of these, 19 were not
considered eligible for the present study according to the
exclusion criteria. Of the 18 eligible subjects, 2 refused to
FIG. 1. Flowchart describing the process of entry into the study.
HEMATOLOGICAL MALIGNANCIES AND NUTRITIONAL STATUS 3
Dow
nloa
ded
by [
191.
191.
99.6
2] a
t 05:
02 0
4 M
arch
201
5
participate. Thus, 16 patients were included in the study and
participated in data collection, as flowchart presented in Fig. 1.
Ten subjects were female (62.5%) with the median age of
47 yr old, ranging between 18.7 and 79.6 yr. The primary
diagnosis of hematologic malignancy was acute leukemia, rep-
resented by 9 individuals (56.2%). Other diagnoses were
chronic leukemia, Hodgkin’s lymphoma, non-Hodgkin’s
lymphoma, and multiple myeloma. Nine patients had no
comorbidities, the remaining 7 presented osteoporosis, type II
diabetes, hypertension, rheumatoid arthritis, depression, gastri-
tis, gastric ulcer, hiatal hernia, esophagitis, hypothyroidism.
Such data are summarized in Table 1.
Nutritional Status, Acute Phase Proteins, and Hemogram
Nutritional state variables, acute phase proteins, and hemo-
gram data are shown in Tables 2 and 3. Regarding nutritional
variables, shown in Table 2, BMI, percentage of weight loss,
and adequacy of mid-upper arm muscle circumference, it was
observed that most of the individuals was overweight accord-
ing to BMI (median D 25.6 kg/m2). Despite the large varia-
tion, the median percentage of weight loss was 0.96%, not
considered a significant loss according to the classification of
Blackburn et al. (20). The median adequacy of mid-upper arm
muscle circumference (99.5%) indicates that individuals were
well nourished according to this parameter. The median values
of albumin, hematocrit, hemoglobin, red blood cells count,
and platelets were lower than the reference values. CRP was
648% higher than the reference value (median D 37.45 mg/L).
For MUAMC, both diagnoses presented similar results, BMI
was slightly higher at p75 in leukemias patients, and, in gen-
eral, lymphoma patients presented lower BMI values. Albumin
concentrations were heterogeneous in patients with leukemia
and were slightly higher (6.4%) than in patients with lym-
phoma, these differences were not significant.
Description of the Parameters of Mononuclear Cells’Functionality and Plasma Oxidative Stress
Results for phagocytic capacity and superoxide anion pro-
duction of mononuclear cells, plasma catalase activity and
plasma lipid peroxidation are shown in Figure 2. Median of
phagocytic capacity was 77.9% higher in patients diagnosed
with lymphoma compared to those diagnosed with leukemia,
but this difference was not statistically significant. On the
other hand, superoxide anion production by mononuclear cells
and plasma catalase activity were 231.6% and 73.8%, respec-
tively, higher in leukemia than in patients with lymphoma. For
lipid peroxidation, the median values were almost the same
for both diagnoses, although the values for leukemia were
more heterogeneous than for lymphomas.
Correlations Between Study Variables
Some variables were selected to be correlated. Of all corre-
lations analysis performed in this study, only the relevant were
chosen to be presented here. Albumin had a moderate inverse
correlation with BMI (r D ¡0.53), with the adequacy of
MUAMC (r D ¡0.35) and a moderate and positive correlation
with percentage of weight loss (r D 0.68). Furthermore, CRP
correlated weakly and positively with BMI (r D 0.17), moder-
ate and positively with adequacy of MUAMC (r D 0.32), and
moderately and inversely with percentage of weight loss (r D
¡0.55). Considering mononuclear cell functions and nutri-
tional status correlations, only phagocytic capacity and BMI
had a moderate and inverse correlation (r D ¡0.31).Other cor-
relations were considered weak (data not shown). Catalase
activity had a moderate and positive correlation with BMI and
MUAMC (r D 0.42 and 0.41, respectively) and a moderate
inverse correlation with percentage of weight loss. Lipid
hydroperoxides were also moderately correlated with BMI
(r D 0.37) and percentage of weight loss (r D ¡0.42). Super-
oxide anion production had a weak and inverse correlation
with plasma catalase activity (r D ¡0.13) and a weak positive
correlation with plasma lipid peroxidation (r D 0.26). Plasma
lipid peroxidation had a strong and positive correlation with
plasma activity of catalase (r D 0.75).
DISCUSSION
The individuals studied here were overweight, according to
BMI, unlike what is usually expected in cancer patients. In
such diseases the deterioration of the patients’ nutritional sta-
tus apparently occurs after the beginning of treatment, and
probably as a consequence of it. Malihi et al. (21) conducted a
study to monitor the nutritional status of patients older than
15 yr diagnosed with acute leukemia before and after
TABLE 1
Participant characteristics (n D 16)
Variable n %
Gender
Female 10 62.5
Male 6 37.5
Age – Mean (minimum; maximum) 16 47 (18.70; 79.60)
Diagnosis
Acute Leukemia 9 56.2
Chronic Leukemia 1 6.2
Hodgkin Lymphoma 2 12.5
Non-Hodgkin Lymphoma 3 18.7
Multiple Myeloma 1 6.2
Comorbidities
Absent 9 56.3
Present 7 43.7
Comorbidities: Osteoporosis, type 2 diabetes, hypertension, rheumatoid arthritis,depression, gastritis, gastric ulcer, hiatal hernia, esophagitis, hypothyroidism.
4 C. DE QUADROS CAMARGO ET AL.
Dow
nloa
ded
by [
191.
191.
99.6
2] a
t 05:
02 0
4 M
arch
201
5
chemotherapy. They observed that, before chemotherapy,
none of the patients, assessed by Patient-Generated Subjective
Global Assessment, presented severe malnutrition (19.05%
were moderately malnourished and 80.95% were eutrophic).
Otherwise, after chemotherapy, 76.01% were classified as
moderately malnourished, 15.87% were severely malnour-
ished, and only 7.94% were eutrophic. Noteworthy, the pres-
ence of weight excess and obesity for such patients early in
treatment might be considered advantageous. Brunner et al.
(22) evaluated the association between BMI at diagnosis and
survival of patients with 60 yr or older with acute myeloid leu-
kemia. Mortality risk increased for patients with a BMI less
than 25 kg/m2 compared to those with BMI higher than or
equal to 30kg/m2. Similarly, Medeiros et al. (23) assessed the
BMI of 1974 adult patients with acute myeloid leukemia,
before chemotherapy treatment, and found that obesity was
associated with better response to the treatment and survival
rates equivalent to those of eutrophic individuals. Better sur-
vival rates were also observed in obese or overweight patients
with lymphoma and diffuse large B cell lymphoma, a type of
non-Hodgkin lymphoma (24).
Evaluation of serum albumin is considered a simple method
for estimating visceral proteins. Malnutrition and systemic
inflammation suppress the synthesis of albumin (25), charac-
terizing it as a negative acute phase protein. In the present
study we found similar concentration of albumin (but lower
than the reference values) for both diagnoses, though slightly
higher for diagnoses of leukemia. Correlating values of serum
TABLE 2
Body weight, height, body mass index, percentage of weight loss, adequacy of mid-upper arm muscle circumference, C-reactive
protein (CRP), albumin and CRP/Albumin ratio of untreated subjects with hematological malignancies (n D 16)
Parameter Median (IQR) Reference value
Body weight (kg) —
All subjects 68.7 [63.7; 79.7]
Leukemia (n D 10) 70.9 [66.0; 81.3]
Lymphoma (n D 5) 64.0 [63.5; 64.6]
Height (m) —
All subjects 1.63 [1.54; 1.73]
Leukemia (n D 10) 1.61 [1.53; 1.80]
Lymphoma (n D 5) 1.60 [1.59; 1.67]
Body mass index (kg/m2) 18.5–24.9
All subjects 25.6 [24.0; 29.2]
Leukemia (n D 10) 26.5 [24.9; 28.2]
Lymphoma (n D 5) 22.7 [22.4; 25.5]
Percentage of weight loss in the last 6 months (%) —
All subjects 0.96 [-1.43; 5.76]
Leukemia (n D 10) 4.64 [0.00; 6.30]
Lymphoma (n D 5) -0.54 [-0.79; -0.13]
Adequacy of mid-upper arm muscle circumference (%) —
All subjects 99.5 [86.9; 111.1]
Leukemia (n D 10) 103.9 [86.9; 111.1]
Lymphoma (n D 5) 95.3 [86.3; 106.3]
Serum CRP (mg/L) < 5.0
All subjects 37.4 [7.2; 68.8]
Leukemia (n D 10) 26.1 [7.6; 54.4]
Lymphoma (n D 5) 63.9 [6.8; 91.5]
Serum Albumin (g/dL) 3.4–5.0
All subjects 3.2 [2.8; 3.6]
Leukemia (n D 10) 3.3 [2.8; 3.6]
Lymphoma (n D 5) 3.1 [3.1; 3.4]
CRP/Albumin ratio —
All subjects 13.7 [2.0; 23.6]
Leukemia (n D 10) 8.9 [2.1; 18.1]
Lymphoma (n D 5) 20.6 [2.0; 31.5]
IQR: Interquartile Range; CRP: C-Reactive Protein.
HEMATOLOGICAL MALIGNANCIES AND NUTRITIONAL STATUS 5
Dow
nloa
ded
by [
191.
191.
99.6
2] a
t 05:
02 0
4 M
arch
201
5
albumin of both diagnoses with indicators of nutritional status,
a moderate inverse correlation was observed with BMI and
MUAMC and strong and positive with percentage of weight
loss. It is expected, in principle, that a better nutritional status
(greater BMI, better adequacy of MUAMC, and less percent-
age of weight loss) would also lead to a greater concentration
of serum albumin, whereas the opposite was found. Consider-
ing newly diagnosed patients were evaluated, it can be pro-
posed that the correlations presented here might be a sign that
physiological changes do not present the same timing when
compared to anthropometrical ones. In hematological malig-
nancies there is another interesting point to be considered in
the relation between albumin and BMI, the prevalence of such
diseases seems to present a direct relation to overweight and
obesity (26,27). Therefore, the expected correlation between
serum albumin and BMI might be disrupted in these diseases
due to commonly high BMI values presented by these patients.
The same unexpected relation with BMI was seen when
CRP and BMI data were contrasted. CRP is a positive acute
phase protein that has its synthesis increased in the liver when
this organ is stimulated by mediators (28) produced by normal
and malignant cells. CRP values were higher in patients with
lymphoma than those with leukemia. Studies consider CRP as
an independent predictor of clinical outcomes or a parameter
for prognosis in patients with certain types of lymphomas
(29,30). As a consequence of high CRP and low albumin
serum concentrations, the ratio between such variables
resulted high values, this parameter may indicate inflammatory
nutritional risk (31). Therefore, a close attention to these
patients must be paid during their clinical course.
In hematological malignancies, it is important to assess the
leukocytes functionality, especially considering that undiffer-
entiated cells and that the chemotherapy treatment might
increase morbidity and mortality of these patients (32). Hof-
mann et al. (33) observed that newly diagnosed patients with
myeloid or acute lymphoblastic leukemia had lower neutrophil
phagocytic capacity than healthy individuals. Hubel et al. (34),
which evaluated the phagocytic capacity of neutrophils from
patients with acute nonlymphocytic leukemia before chemo-
therapy, found that patients with higher phagocytic capacity
also had fewer or milder infections than patients with lower
phagocytic capacity. It is expected, therefore, as shown in this
study, that leukemia patients present a lower mononuclear
cells’ phagocytic capacity compared to patients with lympho-
mas, probably due to the greater number of blast cells in the
peripheral blood. Noteworthy, a moderate and inverse correla-
tion was found between phagocytic capacity and BMI, sug-
gesting that weight excess may be linked with an impaired
leukocyte function in these patients.
Leukemia patients demonstrated greater superoxide anion
production when compared to patients with lymphoma,
although this difference was not significant. Leukemic cells
contain high concentrations of reactive oxygen species, due to
changes in pro and antioxidant pathways. Increased production
TABLE 3
Hematological parameters of subjects with untreated hematological malignancies (n D 16)
Parameter Median (IQR) Reference value
Hematocrit (%) M: 40.0–52.0 / F: 37.0–47.0
All subjects 25.4 [20.6; 35.9]
Leukemia (n D 10) 21.3 [20.4; 25.4]
Lymphoma (n D 5) 36.1 [30.5; 196.6]
Hemoglobin (g/dL) M: 13.0–18.0 / F: 12.0–16.0
All subjects 8.3 [7.2; 11.8]
Leukemia (n D 10) 7.6 [6.9; 8.8]
Lymphoma (n D 5) 11.9 [9.8; 64.0]
Erythrocytes (106/mm3) M: 4.5–6.0 / F: 4.0–5.2
All subjects 2.5 [2.2; 4.1]
Leukemia (n D 10) 2.2 [2.1; 2.8]
Lymphoma (n D 5) 4.4 [3.6; 215.3]
Leukocytes (cells/mm3) 3.800–11.000
All subjects 7860 [4840; 22480]
Leukemia (n D 10) 11205 [5300; 27370]
Lymphoma (n D 5) 6490 [3955; 8535]
Platelets (units/mm3) 150.000–440.000
All subjects 58000 [33000; 136000]
Leukemia (n D 10) 47500 [28000; 74000]
Lymphoma (n D 5) 159000 [136000; 242000]
IQR: Interquartile Range; M: Male; F: Female.
6 C. DE QUADROS CAMARGO ET AL.
Dow
nloa
ded
by [
191.
191.
99.6
2] a
t 05:
02 0
4 M
arch
201
5
of reactive species may be either due to activation of onco-
genes and as a result of mutations independent of oncogenic
activity in mitochondria and cytochrome p450, for example
(5). According to Er et al. (35), the generation of superoxide
anion by leukocytes was significantly higher in patients with
acute myeloid leukemia than in healthy individuals. The super-
oxide anion seems to promote a malignant phenotype in
tumoral (36) environment. Increased production of superoxide
anion in leukemia patients, as observed in the present study,
may promote genetic instability, higher survival, cell growth
and motility, lipid peroxidation, amino acid oxidation, and
damage to DNA (5), if in imbalance with antioxidant protec-
tion. Superoxide dismutase is the enzyme responsible for the
dismutation of superoxide anion into molecular oxygen and
hydrogen peroxide, which is then processed by the catalase
enzyme (5). The correlations between superoxide anion, cata-
lase activity, or lipid peroxides concentration were mostly
weak. This was probably because the superoxide anion was
assessed in mononuclear cells and other parameters were
assayed in plasma. It is worthy to mention that superoxide
anion production is not always modified in hematological
malignancies (37).
As previously mentioned, superoxide dismutase enzyme
reduces concentrations of superoxide anion, creating hydrogen
peroxide, which is decomposed into a hydroxyl radical and
can cause cellular damage. Catalase, in turn, coordinates the
decomposition of 2 molecules of hydrogen peroxide to water
and molecular oxygen (5). Zelen et al. (37) evaluated catalase
activity in plasma of untreated patients with chronic lympho-
cytic leukemia (CLL) and observed an increment in such
activity compared to the activity of healthy individuals. The
same authors also noted that disease progression was associ-
ated with significantly higher catalase activity. In myeloid leu-
kemias, high catalase activity contributes both to disease
progression and resistance to therapy, as a tumor promoter. On
the other hand, in lymphocytic leukemia, reduced catalase
activity contributes to the acquisition of a genomic instability,
favoring mutations, lower defense against peroxides, and a
permissive environment for secondary mutations (5).
Collado et al. (38) evaluated the catalase activity of circu-
lating lymphocytes from untreated patients with CLL and
observed lower activity of this enzyme when compared with
healthy subjects. Zaric et al. (39), also when evaluating
patients with CLL in different stages of the disease, found that
catalase activity in plasma of patients with more advanced dis-
ease was higher than in healthy controls and in patients with
less advanced disease, whereas activity in the cell lysate was
lower. Differences can arise due to experimental conditions
FIG. 2. Phagocytic capacity (A) and superoxide anion production (B) by peripheral mononuclear cells. Plasma lipid hydroperoxides (mmol/mg of protein) (C)
and catalase activity (mM/min/mg of protein) (D) of nontreated subjects with leukemia (n D 10) or lymphoma (n D 5).
HEMATOLOGICAL MALIGNANCIES AND NUTRITIONAL STATUS 7
Dow
nloa
ded
by [
191.
191.
99.6
2] a
t 05:
02 0
4 M
arch
201
5
and working methods (39) still, as pointed out by Irwin et al.
(5), catalase seems to have contradictory roles depending on
type of leukemia and treatment status. In the present study,
there was a wide variation for both catalase activity and for
lipid peroxidation in subjects with leukemia, such variation
may be due to leukemia types and disease stage.
As Zelen et al. (37), who observed an increase in both cata-
lase activity and lipid peroxidation products in plasma of indi-
viduals with CLL, a strong positive correlation between
catalase activity and plasma lipid hydroperoxides was also
revealed in the present study. This might indicate that higher
concentrations of lipid peroxides can promote stimulation of
antioxidant enzymatic system, at least involving catalase, in
these patients. However, lipid peroxides concentration are not
always high in hematological malignancies as showed by the
study of Devi et al. (40), which assessed lipid peroxidation in
plasma of patients with different types of leukemia before
treatment. In the same study, although the generation of super-
oxide anion was high, they found no difference for this param-
eter among the various diagnoses of leukemia.
Similar correlations were found when analyzing if catalase
activity and lipid hydroperoxides were in some way related to
nutritional status, indicating that patients with higher BMI val-
ues and lower percentage of weight loss had higher values of
catalase activity and lipid hydroperoxides. Furukawa et al.
(41) investigating if the oxidative stress was increased in obese
individuals, also positively correlated lipid peroxidation (eval-
uated as plasma thiobarbituric acid reactive substances) with
BMI and waist circumference. Ahmad et al. (42,43), evaluated
lipid peroxidation measuring thiobarbituric acid reactive sub-
stances and lipid hydroperoxides, in subjects with chronic
myeloid leukemia, observed an increase in the lipid peroxida-
tion comparing with values of healthy individuals. The study
of Ahmad et al. (42) have attributed such finding to the
increased generation of free radicals or inadequate clearance
of these species by the antioxidant enzymes. In contrast, the
present study observed a weak correlation between generation
of superoxide anion and lipid peroxidation, the generation of
superoxide anion might be balanced by greater antioxidant
enzyme response. Although we cannot confirm this hypothe-
sis, future studies can be planned to assess such question.
Limitations due to factors such as the heterogeneity of the
diagnoses and the restricted number of subjects included need
to be mentioned. Another limitation found in this study was
the wide age range of the participants, this difference can lead
to biological variation in parameters of cell functionality as
well as differences in oxidative stress parameters and nutri-
tional status of individuals. Future studies must control these
potential confusing factors.
CONCLUSION
Individuals with hematological malignancies are mostly
overweight, according to BMI. This observation might be
responsible to the disruption of the expected relations between
serum albumin or CRP and BMI in clinical nutrition. These
patients also presented clinically relevant alterations in serum
albumin and CRP, suggesting a high nutritional inflammatory
risk. Mononuclear cell functions tend to be decreased in leuke-
mia, when compared to patients with lymphoma. BMI values
correlated inversely with phagocytic capacity of mononuclear
cells, and positively with lipid peroxidation and catalase activ-
ity. In plasma, a strong correlation between plasma lipid per-
oxides concentration and catalase activity was observed. This
information can be potentially applied in further studies to
investigate oxidative stress in these patients with repercussions
to antineoplastic therapy and nutritional interventions. The
findings of the present study reinforce that, besides their BMI,
patients with hematological malignancies require nutritional
counseling. This is especially relevant considering that chemo-
therapy treatment can potentially seriously over compromise
the nutritional status.
ACKNOWLEDGMENTS
We thank the Postgraduate Program in Nutrition, Federal
University of Santa Catarina; Coordination of Improvement of
Higher Education Personnel; National Council for Scientific
and Technological Development; Hematology and Oncology
Department, University Hospital of Federal University of
Santa Catarina; and Luiz Felipe de Souza, student of the Labo-
ratory of Cellular Defenses, for his help in the analysis of cata-
lase activity.
FUNDING
Financial support was provided by the Postgraduate Pro-
gram in Nutrition, Federal University of Santa Catarina; the
National Council for Scientific and Technological Develop-
ment; and the Scholarship Program-Social Demand-Coordina-
tion of Improvement of Higher Education Personnel.
REFERENCES1. Ruddon RW: Cancer Biology. Oxford, UK: Oxford University Press,
2007.
2. National Cancer Institute: Cancer Topics—Leukemia. United States of
America: NCI, 2013. Retrieved from http://www.cancer.gov/cancer
topics/types/leukemia
3. Ginderachter JA, Movahedi K, Ghassabeh GH, Meerschaut S, Beschin A,
et al.: Classical and alternative activation of mononuclear phagocytes:
Picking the best of both worlds for tumor promotion. Immunobiology
211, 487–501, 2006.
4. Siveen KS and Kuttan G: Role of macrophages in tumour progression.
Immunol Lett 123, 97–102, 2009.
5. Irwin ME, Rivera-Del Valle N, and Chandra J: Redox control of leuke-
mia: from molecular mechanisms to therapeutic opportunities. Antioxid
Redox Signal 18, 1349–1383, 2013.
6. Karihtala P and Soini Y: Reactive oxygen species and antioxidant mecha-
nisms in human tissues and their relation to malignancies. Acta Pathol
Microbiol Immunol 115, 81–103, 2007.
8 C. DE QUADROS CAMARGO ET AL.
Dow
nloa
ded
by [
191.
191.
99.6
2] a
t 05:
02 0
4 M
arch
201
5
7. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, et al.:. Patho-
logical aspects of lipid peroxidation. Free Radic Res 44, 1125–1171,
2010.
8. Brasil Minist�erio da Sa�ude, Instituto Nacional de Cancer, Consenso
Nacional de Nutric~ao Oncol�ogica. Rio de Janeiro, Brazil: Inca, 2009.
9. Mcmillan DC: Systemic inflammation, nutritional status and survival in
patients with cancer. Curr Opin Clin Nutr Metab Care 12, 223–226, 2009.
10. Frisancho AR: New norms of upper limb fat and muscle areas for assess-
ment of nutritional status. Am J Clin Nutr 34, 2540–2545, 1981.
11. World Health Organization: Physical Status: The Use and Interpretation
of Antropometry (Technical Report, n�. 854). Geneva, Switzerland: World
Health Organization, 1995.
12. Rosen, H and Gordon S: Monoclonal antibody to the murine type 3 com-
plement receptor inhibits adhesion of myelomonocytic cells in vitro and
inflammatory cell recruitment in vivo. Journal of Experimental Medicine
166, 1685–1701, 1987.
13. Pipe RK, Coles JA, and Farley SR: Assays for measuring immune
response in the mussel Mytilus edulis. Technology Fish Immunology 4,
93–100, 1995.
14. Choi HS, Kim JW, Cha YN, and Kim C: A quantitative nitroblue tetrazo-
lium assay for determining intracellular superoxide anion production in
phagocytic cells. J Immunoassay Immunochem 27, 31–44, 2006.
15. Aebi H: Catalase in vitro.Methods Enzymol 105, 121–126, 1984.
16. Bradford MM: A rapid and sensitive method for the quantitation of micro-
gram quantities utilizing the principle of protein dye binding. An Biochem
142, 79–83, 1976.
17. Nourooz-Zadeh J, Tajaddini-Sarmadi J, and Wolff SP: Measurement of
plasma hydroperoxide concentrations by the ferrous oxidation-xylenol
orange assay in conjunction with triphenylphosphine. Anal Biochem 220,
403–409, 1994.
18. Ledue TB, Weiner DL, Sipe JD, Poulin SE, et al.: Analytical evaluation
of particle-enhanced immunonephelometric assays for C-reactive protein,
serum amyloid A and mannose-binding protein in human serum. Ann
Clin Biochem 35, 745–753, 1998.
19. Lasky FD, Li ZM, and Shaver DD: Evaluation of a bromocresol purple
method for the determination of albumin adapted to the DuPont aca dis-
crete clinical analyzer. Clin Biochem 18, 290–296, 1985.
20. Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, and Smith MF:
Nutritional and metabolic assessment of the hospitalized patient. J Parent
Enter Nutr 1, 11–22, 1977.
21. Malihi Z, Kandiah M, Chan YM, Hosseinzadeh M, Azadi MS, et al.:
Nutritional status and quality of life in patients with acute leukaemia prior
to and after induction chemotherapy in three hospitals in Tehran, Iran: a
prospective study. J Hum Nutr Diet 26(Suppl 1), 123–131, 2013.
22. Brunner AM, Sadrzadeh H, Feng Y, Drapkin BJ, Ballen KK, et al.: Asso-
ciation between baseline body mass index and overall survival among
patients over age 60 with acute myeloid leukemia. Am J Hematol 88,
642–646, 2013.
23. Medeiros BC, Othus M, Estey EH, Fang M, and Appelbaum FR: Impact
of body-mass index on the outcome of adult patients with acute myeloid
leukemia. Haematologica 97, 1401–1404, 2012.
24. Carson KR, Bartlett NL, Mcdonald JR, Luo S, Zeringue A, et al.:
Increased body mass index is associated with improved survival in United
States veterans with diffuse large B-cell lymphoma. J Clin Oncol 30,
3217–3222, 2012.
25. Gupta D and Lis CG: Pretreatment serum albumin as a predictor of cancer
survival: A systematic review of the epidemiological literature. Nutrition
Journal 9, 2–16, 2010.
26. MacInnis RJ, English DR, Hopper JL, and Giles GG: Body size and com-
position and the risk of lymphohematopoietic malignancies. J Natl Can-
cer Inst 97, 1154–1157, 2005.
27. S€oderberg K, Kaprio J, Verkasalo PK, Pukkala E, Koskenvuo M, et al.:
Overweight, obesity and risk of haematological malignancies: a cohort
study of Swedish and Finnish twins. Eur J Cancer 45, 1232–1238, 2009.
28. Majello B, Arcone R, Toniatti C, and Ciliberto G: Constitutive
and IL-6-induced nuclear factors that interact with the human
C-reactive protein promoter. The EMBO Journal 9, 457–465,
1990.
29. Cao Y, Shi Y, Chen J, Tan Y, Cai Y, et al.: Serum C-reactive protein as
an important prognostic variable in patients with diffuse large B cell lym-
phoma. Tumor Biology 33, 1039–1044, 2012.
30. Li Y, Li Z, Xia Y, Huang J, Huang H, et al.:. Serum C-reactive protein
(CRP) as a simple and independent prognostic factor in extranodal natural
killer/T-cell lymphoma. nasal type. Plos One 8, e64158, 2013.
31. Crozier JE, Leitch EF, McKee RF, Anderson JH, Horgan PG, et al.: Rela-
tionship between emergency presentation, systemic inflammatory
response, and cancer-specific survival in patients undergoing potentially
curative surgery for colon cancer. The American Journal of Surgery 197,
544–549, 2009.
32. Levine AS, Siegel SE, Schreiber AD, Hauser J, Preisler H, et al.: Pro-
tected environments and prophylactic antibiotics—a prospective con-
trolled study of their utility in the therapy of acute leukemia. N Engl J
Med 288, 477–483, 1973.
33. Hofmann WK, Stauch M, and Hoffken K: Impaired granulocytic function
in patients with acute leukaemia: only partial normalisation after success-
ful remission-inducing treatment. J Cancer Res Clin Oncol 124, 113–116,
1998.
34. Hubel K, Hegener K, Schnell R, Mansmann G, Oberhauser F, et al.: Sup-
pressed neutrophil function as a risk factor for severe infection after cyto-
toxic chemotherapy in patients with acute nonlymphocytic leukemia. Ann
Hematol 78, 73–77, 1999.
35. Er T, Tsai S, Wu S, Chiang W, Lin H, et al.: Antioxidant status and super-
oxide anion radical generation in acute myeloid leukemia. Clin Biochem
40, 1015–1019, 2007.
36. Tanaka M, Kuribayashi K, Kogawa K, Nakamura K, and Watanabe N:
Intracellular superoxide dismutase activity defines invasiveness of the
murine T-lymphoma cell line L5187Y-ML25 in vitro and in vivo. Leuk
Res 37, 89–92, 2013.
37. Zelen I, Djurdjevic P, Popovic S, Stojanovic M, Jakovljevic V, et al.:.
Antioxidant enzymes activities and plasma levels of oxidative stress
markers in B chronic lymphocytic leukemia patients. J Buon 15, 330–
336, 2010.
38. Collado R,Oliver I, Tormos C, Egea M, Miguel A, et al.:. Early ROS-
mediated DNA damage and oxidative stress biomarkers in Monoclonal B
Lymphocytosis. Cancer Lett 317, 144–149, 2012.
39. Zaric M, Mitrovic M, Nikolic I, Popovic S, Djurdjevic P, et al.: Activity
of superoxide dismutase, catalase, and glutathione peroxidase in plasma
and lysates of chronic lymphocytic leukemia patients. Med Cas 45, 9–16,
2011.
40. Devi GS, Prasad MH, Saraswathi I, Raghu D, Rao DN, et al.: Free radi-
cals antioxidant enzymes and lipid peroxidation in different types of leu-
kemias. Clin Chim Acta 293, 53–62, 2000.
41. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, et al.:
Increased oxidative stress in obesity and its impact on metabolic syn-
drome. J Clin Invest 114, 1752–1761, 2004.
42. Ahmad R, Tripathi AK, Tripathi P, Singh R, Singh S, et al.: Oxidative
stress and antioxidant status in patients with chronic myeloid leukemia.
Indian J Clin Biochem 23, 328–333, 2008.
43. Ahmad R, Tripathi AK, Tripathi P, Singh R, Singh S, et al.: Studies on
lipid peroxidation and nonenzymatic antioxidant status as indices of oxi-
dative stress in patients with chronic myeloid leukaemia. Singapore Med
J 51, 110–115, 2010.
HEMATOLOGICAL MALIGNANCIES AND NUTRITIONAL STATUS 9
Dow
nloa
ded
by [
191.
191.
99.6
2] a
t 05:
02 0
4 M
arch
201
5